HIGHLIGHTS
- Who: . and colleagues from the Essen University Hospital, Germany have published the research work: The role of circulating tumor DNA in melanomas of the uveal tract, in the Journal: (JOURNAL)
- Future: Studies in the form of clinical trials are required to explore and validate these clinical utilities in the context of UM. Whether ctDNA-based approaches may inform adjuvant treatment in UM remains to be explored in future studies. Cost-effectiveness of ctDNA-based strategies compared to traditional methods is another key parameter that needs to be assessed in future studies. Strikingly the two Frontiers . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.